MariMed Inc.
MRMD
$0.0725
$0.00141.97%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.84% | 6.30% | 8.47% | 10.97% | 10.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.84% | 6.30% | 8.47% | 10.97% | 10.97% |
| Cost of Revenue | 13.28% | 15.02% | 11.43% | 15.13% | 13.93% |
| Gross Profit | -8.16% | -4.63% | 4.75% | 5.96% | 7.43% |
| SG&A Expenses | 9.74% | 16.06% | 23.14% | 28.48% | 28.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.89% | 15.42% | 15.82% | 20.08% | 19.39% |
| Operating Income | -91.41% | -74.38% | -51.94% | -49.84% | -39.51% |
| Income Before Tax | 13.35% | 39.84% | -278.70% | -190.84% | -159.74% |
| Income Tax Expenses | 8.04% | -13.30% | -46.10% | 52.86% | 82.10% |
| Earnings from Continuing Operations | 2.28% | 24.24% | -1,163.70% | -394.98% | -291.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -28.57% | -54.17% | -3,300.00% | -58.33% | 33.78% |
| Net Income | 2.19% | 24.12% | -1,171.74% | -396.84% | -293.21% |
| EBIT | -91.41% | -74.38% | -51.94% | -49.84% | -39.51% |
| EBITDA | -41.89% | -37.77% | -22.58% | -21.65% | -15.26% |
| EPS Basic | 3.81% | 25.35% | -1,780.00% | -366.09% | -274.90% |
| Normalized Basic EPS | -281.13% | -146.39% | -95.92% | -90.64% | -82.62% |
| EPS Diluted | 3.81% | 25.35% | -1,780.00% | -366.09% | -279.12% |
| Normalized Diluted EPS | -281.13% | -146.39% | -95.74% | -89.86% | -80.87% |
| Average Basic Shares Outstanding | 2.58% | 4.37% | 6.69% | 8.77% | 9.33% |
| Average Diluted Shares Outstanding | 2.58% | 4.37% | 3.59% | 2.51% | 0.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.29% | -0.70% | 0.90% | -1.26% | -1.40% |